Seres Therapeutics, Inc. financial data

Symbol
MCRB on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Sidney Street, Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Seres Health, Inc. (to 5/14/2015)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 228 % -5.09%
Quick Ratio 27 %
Debt-to-equity -1.62K % -175%
Return On Equity 341 %
Return On Assets -22.4 % +74.5%
Operating Margin -60.7 % +98.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 151M shares +19.8%
Common Stock, Shares, Outstanding 151M shares +19.6%
Entity Public Float 463M USD +93%
Common Stock, Value, Issued 151K USD +18.9%
Weighted Average Number of Shares Outstanding, Basic 146M shares +16.1%
Weighted Average Number of Shares Outstanding, Diluted 146M shares +16.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 127M USD +2381%
Revenue from Contract with Customer, Excluding Assessed Tax 7.13M USD -95%
Research and Development Expense 124M USD -30.3%
General and Administrative Expense 80.7M USD -3.41%
Operating Income (Loss) -77M USD +70.5%
Nonoperating Income (Expense) -5.68M USD -67.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -82.7M USD +68.8%
Earnings Per Share, Basic -0.59 USD/shares +74%
Earnings Per Share, Diluted -0.59 USD/shares +74%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 111M USD +17.2%
Inventory, Net 42M USD
Assets, Current 165M USD +42.3%
Property, Plant and Equipment, Net 19.1M USD -21.4%
Operating Lease, Right-of-Use Asset 106M USD -2.98%
Other Assets, Noncurrent 41.5M USD +267%
Assets 341M USD +26.3%
Accounts Payable, Current 5.22M USD -57.6%
Employee-related Liabilities, Current 6.14M USD -10.8%
Liabilities, Current 98.5M USD +54.3%
Operating Lease, Liability, Noncurrent 103M USD -3.14%
Other Liabilities, Noncurrent 1.68M USD +12.9%
Liabilities 401M USD +26.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -1.02B USD -8.84%
Stockholders' Equity Attributable to Parent -59.7M USD -24.8%
Liabilities and Equity 341M USD +26.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.2M USD +54%
Net Cash Provided by (Used in) Financing Activities 18.8M USD +232%
Net Cash Provided by (Used in) Investing Activities -62K USD -102%
Common Stock, Shares Authorized 240M shares +20%
Common Stock, Shares, Issued 151M shares +19.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -68.2M USD -156%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 120M USD +16.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.58M USD +106%
Deferred Tax Assets, Valuation Allowance 313M USD +12.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 342M USD +11.4%
Operating Lease, Liability 112M USD +0.63%
Payments to Acquire Property, Plant, and Equipment 62K USD -98.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -82.7M USD +68.7%
Lessee, Operating Lease, Liability, to be Paid 174M USD -5.44%
Property, Plant and Equipment, Gross 71.5M USD +1.08%
Operating Lease, Liability, Current 8.83M USD +84.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 22.7M USD +7.14%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.1M USD +15.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 61.6M USD -14.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23.3M USD +7.32%
Deferred Tax Assets, Operating Loss Carryforwards 143M USD +7.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 13.5M USD +7.99%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.6M USD
Operating Lease, Payments 15.8M USD +73.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 6.4M USD -0.88%
Share-based Payment Arrangement, Expense 33.7M USD +23.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%